Valentina Lombardo

6PUBLICATIONS
23CO-AUTHORS
Molecular targetsHaematological tumoursCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 09, 2025
Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody-drug conjugates: a narrative review.

Giuseppa Scandurra, Filippo Marano, Vittorio Gebbia

|May 28, 2025
Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD Assessment.

Giovanni Luca Scaglione, Valentina Lombardo, Maurizio Polano

|Jan 08, 2025
Identification of the novel BRCA1 c.2463_2464delTA mutation in two high grade serous ovarian cancer sisters and potential dosage effects implications: a case report.

Valentina Lombardo, Giuseppa Scandurra, Angela Pettinato

|Jul 13, 2024
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful?

Giuseppa Scandurra, Valentina Lombardo, Giuseppe Scibilia

|Dec 09, 2023
Homologous Recombination Deficiency (HRD) Scoring, by Means of Two Different Shallow Whole-Genome Sequencing Pipelines (sWGS), in Ovarian Cancer Patients: A Comparison with Myriad MyChoice Assay.

Giovanni L Scaglione, Sandro Pignata, Angela Pettinato

|Oct 27, 2022
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network.

Giuseppe Luigi Banna, Umberto Basso, Emilio Francesco Giunta

Pageof 1

Frequent Collaborators

4 joint publications

Paolo Scollo

3 joint publications

Giovanni Luca Scaglione

2 joint publications

Giuseppa Scandurra

1 joint publications

Giuseppe Luigi Banna